[Pathophysiological considerations on the therapeutic use of monoamine oxidase inhibitors]. 1962

J A SCHNEIDER, and K F FINGER, and J N PEREIRA

UI MeSH Term Description Entries
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase

Related Publications

J A SCHNEIDER, and K F FINGER, and J N PEREIRA
April 2006, Nature reviews. Neuroscience,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
February 1960, Angiology,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
January 1991, Revista de medicina de la Universidad de Navarra,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
April 1965, Lancet (London, England),
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
August 1983, Journal of clinical psychopharmacology,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
July 1960, Psychiatria et neurologia,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
June 1995, Neurology,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
August 1980, Biological psychiatry,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
September 1969, Les Cahiers du College de medecine des hopitaux de Paris,
J A SCHNEIDER, and K F FINGER, and J N PEREIRA
October 1960, Biochemical pharmacology,
Copied contents to your clipboard!